• Explore /
  • Poster
  • / Induction chemotherapy (IC) docetaxel (T), cisplatin (P), 5-fluorouracil (F) (TPF), or TP followed by concomitant boost radiotherapy (R) with or without cetuximab (E) for functional organ preservation (FOP) of resectable laryngeal and hypopharyngeal cancer (LHSCC): First results of the phase II randomized DeLOS-II study.

Induction chemotherapy (IC) docetaxel (T), cisplatin (P), 5-fluorouracil (F) (TPF), or TP followed by concomitant boost radiotherapy (R) with or without cetuximab (E) for functional organ preservation (FOP) of resectable laryngeal and hypopharyngeal cancer (LHSCC): First results of the phase II randomized DeLOS-II study.

Abstract Poster

Authors

null

Andreas Dietz

University of Leipzig, Leipzig, Germany

Andreas Dietz , Michael Flentje , Rudolf Hagen , Ulrike Bockmuehl , Oliver Koelbl , Volker Schilling , Georg Maschmeyer , Ursula Schroeder , Christian Sittel , Martin Goerner , Thomas Lenarz , Jens Peter Klussmann , Orlando Guntinas-Lichius , Claudia Rudack , Sabine Reinisch , Thomas Foerg , Martin Westhofen , Hans Juergen Welkoborsky , Dirk Esser , Ulrich Keilholz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Head and Neck Cancer

Clinical Trial Registration Number

NCT00508664

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 6016^)

DOI

10.1200/jco.2014.32.15_suppl.6016

Abstract #

6016^

Poster Bd #

31

Abstract Disclosures

Similar Posters

First Author: Pol M. Specenier

First Author: Andreas Dietz

First Author: Ricard Mesia Sr.

First Author: Felix Keil